Published 21:08 IST, December 16th 2020
BBL's Covaxin's phase-1 trial's interim findings indicate vaccine 'well-tolerated'
Interim findings from phase-1 trials of BBL's 'Covaxin' was well-tolerated in all dose groups with no serious adverse events, as it awaits DGCI's emergency nod
null | Image:
self
Advertisement
21:08 IST, December 16th 2020